Histone Deacetylase Inhibitors and Diabetic Kidney Disease

Despite recent clinical trial advances and improvements in clinical care, kidney disease due to diabetes remains the most common cause of chronic kidney failure worldwide. In the search for new treatments, recent attentions have turned to drug repurposing opportunities, including study of the histon...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadden, Mitchell J., Advani, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165182/
https://www.ncbi.nlm.nih.gov/pubmed/30189630
http://dx.doi.org/10.3390/ijms19092630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165182/
https://www.ncbi.nlm.nih.gov/pubmed/30189630
http://dx.doi.org/10.3390/ijms19092630

Ejemplares similares